Economic benefits associated with treatment-free survival of immuno-oncology agents among untreated patients with intermediate/poor-risk advanced or metastatic renal cell carcinoma
Conference Paper
Full Text
Duke Authors
Cited Authors
- Harrison, M; Regan, M; Atkins, M; Rao, S; Yang, S; Johansen, J; Du, E; Gu, C; Fadli, E; Betts, K; McDermott, D
Published Date
- November 6, 2019
Published In
Volume / Issue
- 7 /
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 2051-1426